| Alan Hoang, MD | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Alan Hoang |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013337401 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vanderbilt University Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
Lexicon Pharmaceuticals, Inc., announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November 25, 2009 at 2:30 pm local time at the session entitled, "Therapeutic insights in functional digestive disorders."
A.I. researchers at Stevens Institute of Technology have developed a system that can detect when a person is eating and calculate how many carbohydrates they are consuming with unprecedented accuracy and speed.
Although immigrants from Italy and their offspring form one of the largest demographic groups in Switzerland, there are hardly any studies on their state of health and risk of mortality. In a first for Switzerland, Silvan Tarnutzer and Matthias Bopp from the University of Zurich's Institute of Social and Preventative Medicine calculated unbiased mortality risks for people with an Italian migrant background.
For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
› Verified 2 days ago
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Lexicon Pharmaceuticals, Inc., announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November 25, 2009 at 2:30 pm local time at the session entitled, "Therapeutic insights in functional digestive disorders."
A.I. researchers at Stevens Institute of Technology have developed a system that can detect when a person is eating and calculate how many carbohydrates they are consuming with unprecedented accuracy and speed.
Although immigrants from Italy and their offspring form one of the largest demographic groups in Switzerland, there are hardly any studies on their state of health and risk of mortality. In a first for Switzerland, Silvan Tarnutzer and Matthias Bopp from the University of Zurich's Institute of Social and Preventative Medicine calculated unbiased mortality risks for people with an Italian migrant background.
For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan Hoang, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Alan Hoang, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
Lexicon Pharmaceuticals, Inc., announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November 25, 2009 at 2:30 pm local time at the session entitled, "Therapeutic insights in functional digestive disorders."
A.I. researchers at Stevens Institute of Technology have developed a system that can detect when a person is eating and calculate how many carbohydrates they are consuming with unprecedented accuracy and speed.
Although immigrants from Italy and their offspring form one of the largest demographic groups in Switzerland, there are hardly any studies on their state of health and risk of mortality. In a first for Switzerland, Silvan Tarnutzer and Matthias Bopp from the University of Zurich's Institute of Social and Preventative Medicine calculated unbiased mortality risks for people with an Italian migrant background.
For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
› Verified 2 days ago
John Downing, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Miss Faith Nance, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N Ste 202, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 | |
Dr. Holly Ende, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1301 Medical Center Dr, 4648 Tvc, Nashville, TN 37232 Phone: 225-936-9765 | |
Dr. Catherine Jane Coleman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N, Suite 202, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 | |
Katherine Loh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Nicholas Wittig, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N Ste 201, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 |